Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections

dc.commentsCEB46988por
dc.contributor.authorPires, Diana P.por
dc.contributor.authorMelo, Luís D. R.por
dc.contributor.authorBoas, Diana Patrícia Andrade Vilaspor
dc.contributor.authorSillankorva, Sannapor
dc.contributor.authorAzeredo, Joanapor
dc.date.accessioned2017-10-02T10:20:38Z
dc.date.available2017-10-02T10:20:38Z
dc.date.issued2017-10
dc.date.updated2017-09-30T17:30:40Z
dc.description.abstractThe complex heterogeneous structure of biofilms confers to bacteria an important survival strategy. Biofilms are frequently involved in many chronic infections in consequence of their low susceptibility to antibiotics as well as resistance to host defences. The increasing need of novel and effective treatments to target these complex structures has led to a growing interest on bacteriophages (phages) as a strategy for biofilm control and prevention. Phages can be used alone, as a cocktail to broaden the spectra of activity, or in combination with other antimicrobials to improve their efficacy. Here, we summarize the studies involving the use of phages for the treatment or prevention of bacterial biofilms, highlighting the biofilm features that can be tackled with phages or combined therapy approaches.por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.description.sponsorshipThis work was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the project PTDC/BBB-BSS/6471/2014, the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER-006684). This work was also supported by BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by the European Regional Development Fund under the scope of Norte2020 – Programa Operacional Regional do Norte.por
dc.distributioninternationalpor
dc.identifier.citationPires, Diana P.; Melo, Luís D. R.; Vilas Boas, Diana; Sillankorva, Sanna; Azeredo, Joana, Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Current Opinion in Microbiology, 39, 48-56, 2017por
dc.identifier.doi10.1016/j.mib.2017.09.004por
dc.identifier.issn1369-5274por
dc.identifier.pmid28964986por
dc.identifier.urihttps://hdl.handle.net/1822/46544
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherElsevierpor
dc.relationPTDC/BBB-BSS/6471/2014por
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147337/PTpor
dc.rightsopenAccesspor
dc.subject.wosScience & Technologypor
dc.titlePhage therapy as an alternative or complementary strategy to prevent and control biofilm-related infectionspor
dc.typearticle
dspace.entity.typePublicationen
oaire.citationConferencePlaceNetherlands
oaire.citationEndPage56por
oaire.citationStartPage48por
oaire.citationVolume39por
sdum.journalCurrent Opinion in Microbiologypor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
document_46988_1.pdf
Tamanho:
751.82 KB
Formato:
Adobe Portable Document Format